Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine
about
The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulationProtective and damaging effects of stress mediators: central role of the brainPsychopharmacotherapy of posttraumatic stress disorderStress time-dependently influences the acquisition and retrieval of unrelated information by producing a memory of its ownOverexpression of Mineralocorticoid Receptors Partially Prevents Chronic Stress-Induced Reductions in Hippocampal Memory and Structural PlasticityTianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled studyLong-term ω-3 fatty acid supplementation induces anti-stress effects and improves learning in rats.Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat.Acute episodes of predator exposure in conjunction with chronic social instability as an animal model of post-traumatic stress disorder.Traumatic stress: effects on the brainFunctional neuroimaging in post-traumatic stress disorder.Neuroimaging in posttraumatic stress disorder and other stress-related disorders.Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.From molecule to market: steroid hormones and financial risk-taking.Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease.Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling.Tissue plasminogen activator and plasminogen mediate stress-induced decline of neuronal and cognitive functions in the mouse hippocampus.Neuroplasticity and major depression, the role of modern antidepressant drugsWhat is the functional significance of chronic stress-induced CA3 dendritic retraction within the hippocampus?A double-blind, rct testing beneficial modulation of BDNF in middle-aged, life style-stressed subjects: a clue to brain protection?Monoamine reuptake inhibitors in Parkinson's disease.Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stressThe ever-changing brain: cellular and molecular mechanisms for the effects of stressful experiences.Establishing an agenda for translational research on PTSD.The As and Ds of stress: metabolic, morphological and behavioral consequences.Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators.Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems.The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building?Cognitive role of neurogenesis in depression and antidepressant treatment.Tianeptine: an antidepressant with memory-protective properties.Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited.Structural plasticity of interneurons in the adult brain: role of PSA-NCAM and implications for psychiatric disorders.Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: a critical review.Genetic findings in obsessive-compulsive disorder connect to brain-derived neutrophic factor and mammalian target of rapamycin pathways: implications for drug development.Plasticity-related genes in brain development and amygdala-dependent learning.The protective effect of tianeptine on Gp120-induced apoptosis in astroglial cells: role of GS and NOS, and NF-κB suppressionSerum brain-derived neurotrophic factor (BDNF) concentrations in pregnant women with post-traumatic stress disorder and comorbid depression.Tianeptine combination for partial or non-response to selective serotonin re-uptake inhibitor monotherapy.Neurovascular plasticity of the hippocampus one week after a single dose of ketamine in genetic rat model of depression.
P2860
Q24613593-093B4CF1-A68D-4EFA-A1CD-94311F9A10C1Q24635626-DDFA3048-F362-45DF-8FEC-994E06449DBAQ24657148-08429FFF-3A8F-4E63-85D6-6FAC881B071EQ26801669-E9FC1A2E-66F3-41AF-B045-96C3EB974D02Q27346949-94A17B7A-B08F-4F2A-BEE2-8F4BF3742744Q28268467-1C8AFF2B-28E5-46EE-82B0-BB811EF603A2Q30453301-A542C2DD-E993-48EC-945B-10C8C863EC4FQ30477109-094ECACF-F6AB-42D0-B288-F669F0C24CA4Q30493506-8147DE14-F7C9-4E20-B68A-6D34644976CCQ31099484-767B2F68-047D-4A59-8346-BDBBCBD9C4F1Q31108821-C7187711-6790-451C-9CE3-3EF736D4B003Q31135448-863B4FAB-2EDE-4932-A60D-0D7C11E0C2CEQ33442474-360B9237-910C-46BE-A270-F2AFA3644EE6Q33683413-8E5BE9CA-5D78-4274-AEEB-FD152100DF22Q33829618-488F7DEF-DBCA-43E9-8D11-48608B1231B9Q33966168-EC274E4D-427C-4C36-86A2-DAD02431CD4CQ34137906-D1029A61-44D2-4B41-B8F2-0C92F67355F2Q34212891-B81DE3CB-795D-4731-BE8F-36BCA6CD8BFEQ34381499-68A31422-AE1B-420F-95DF-B836A340A444Q34802496-FB6ACE43-E55E-4792-9226-8906D9097892Q34910290-C4C7BA17-A429-4891-8D12-E638A038721AQ35165280-4F002530-70B0-4B55-AE8E-5096CFA4B244Q35381067-AEA82E55-BC58-41FC-B17F-92D6E8688ABAQ35641897-8970F774-5AE8-4791-8567-C031451FD335Q36557714-D4D8F829-C826-47CE-82BB-FF8B626E8126Q36710935-75A2E592-DFA4-4C83-B32B-2D894E515411Q36776088-64730B3A-D54E-4309-AB85-25B4BF8545A1Q36871849-C419A660-1DCE-46F4-B88D-C18ED5E6E636Q36972430-DD77E436-20F1-4A2E-B878-28896369AE1CQ37210811-82C38E7A-1259-4D00-89F3-218B0AF61A83Q37239732-1BDE21E2-DA31-42AF-A8F1-572937341B4CQ37891098-DD8E9AF9-4D3B-4012-BEE6-470D668FCBDEQ38077106-1C621B4D-D4B7-43FF-BE9C-F759226EBCB3Q38093228-37CDC717-F8F1-4D85-8D45-0F21C42A69B8Q38246625-A3364D70-1795-4422-B47A-9D9D6338B040Q38595350-75F97CC8-E0C4-4D0A-B914-A2516399A59EQ39606968-C9D59512-3AE2-4566-AE77-8D9B4572B29EQ40747906-C5BC29DE-C967-44E5-9DC0-D0DB46CEC802Q44519573-7A5DD280-B3CA-4600-A054-53EBDF785C6CQ46325049-42BCFA73-C409-490A-9997-2C541E407362
P2860
Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Molecular mechanisms of neurop ...... ons: the example of tianeptine
@ast
Molecular mechanisms of neurop ...... ons: the example of tianeptine
@en
Molecular mechanisms of neurop ...... ons: the example of tianeptine
@nl
type
label
Molecular mechanisms of neurop ...... ons: the example of tianeptine
@ast
Molecular mechanisms of neurop ...... ons: the example of tianeptine
@en
Molecular mechanisms of neurop ...... ons: the example of tianeptine
@nl
prefLabel
Molecular mechanisms of neurop ...... ons: the example of tianeptine
@ast
Molecular mechanisms of neurop ...... ons: the example of tianeptine
@en
Molecular mechanisms of neurop ...... ons: the example of tianeptine
@nl
P1476
Molecular mechanisms of neurop ...... ons: the example of tianeptine
@en
P2093
Bruce S McEwen
Sumantra Chattarji
P304
P356
10.1016/J.EURONEURO.2004.09.008
P407
P478
14 Suppl 5
P577
2004-12-01T00:00:00Z